Live Quote · NASDAQINOHealthcare· Biotechnology

Inovio Pharmaceuticals, Inc.

$1.22 2.52%(+$0.03)
TickerSpark Score
45/100
Weak
40
Valuation
20
Profitability
55
Growth
60
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INO research report →

52-Week Range10% of range
Low
$1.03
Current
$1.22
High
$2.98
Company Overviewwww.inovio.com

About the company

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases.

CEO
Jacqueline E. Shea
IPO
1998
Employees
134
HQ
Plymouth Meeting, PA, US

Price Chart

-42.99% · this period
$2.87$1.96$1.05Jul 02Dec 31Jul 02
Valuation
Market Cap
$65.38M
P/E
-0.72
P/S
0.00
P/B
138.94
EV/EBITDA
-0.58
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-666.47%
ROIC
-567.11%
Growth & Income
Revenue
$65.34K · -69.99%
Net Income
$-84,945,901 · 20.80%
EPS
$-1.81 · 54.18%
Op Income
$-86,822,104
FCF YoY
14.97%
Performance & Tape
52W High
$2.98
52W Low
$1.03
50D MA
$1.19
200D MA
$1.72
Beta
1.47
Avg Volume
2.61M

Get TickerSpark's AI analysis on INO

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
May 20, 26YARNO WENDY Lother41,800
May 20, 26YARNO WENDY Lother34,200
May 20, 26Shepard Jayother41,800
May 20, 26Shepard Jayother34,200
May 20, 26Miller Ann Calbyother41,800
May 20, 26Miller Ann Calbyother34,200
May 20, 26Weiner David B.other41,800
May 20, 26Weiner David B.other34,200
May 20, 26Zoth Lota S.other41,800
May 20, 26Zoth Lota S.other34,200
Coverage · INO

Our INO coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on INO yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate INO report →
Internal Compare

Similar companies

Peers in the same neighborhood.